Lisa Ley
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- J Koudstaal (3 shared papers)G. Harms (3 shared papers)Harry van Goor (3 shared papers)Mj Hardonk (3 shared papers)Lou A. Smets (2 shared papers)Michael J. Pishvaian (7 shared papers)John L. Marshall (6 shared papers)J. L. V. Broers (1 shared paper)
- Journals
- Journal of Clinical Oncology (11 papers)Future Oncology (2 papers)Histochemistry and Cell Biology (2 papers)Proceedings of the National Academy of Sciences (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Lisa Ley
27 papers receiving 515 citations
Peers
Comparison fields: 5 of 82
- Oncology 211
- Cancer Research 79
- Cell Biology 67
- Immunology and Allergy 19
- Molecular Biology 187
Countries citing papers authored by Lisa Ley
This map shows the geographic impact of Lisa Ley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Ley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Ley more than expected).
Fields of papers citing papers by Lisa Ley
This network shows the impact of papers produced by Lisa Ley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Ley. The network helps show where Lisa Ley may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Ley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 85 | |
| 2 | 1986 | 85 | |
| 3 | 1985 | 50 | |
| 4 | 2015 | 39 | |
| 5 | 1983 | 36 | |
| 6 | 1990 | 35 | |
| 7 | 2014 | 27 | |
| 8 | 1987 | 26 | |
| 9 | 1974 | 25 | |
| 10 | 2016 | 22 | |
| 11 | 2013 | 18 | |
| 12 | 1993 | 17 | |
| 13 | 2019 | 16 | |
| 14 | Double immunohistochemical demonstration of antigen expression and DNA-incorporated 5-bromodeoxyuridine in frozen and plastic embedded sections. | 1988 | 13 |
| 15 | 1988 | 11 | |
| 16 | 1975 | 9 | |
| 17 | 1994 | 7 | |
| 18 | 2024 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2020 | 3 |
About Lisa Ley
Lisa Ley is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 29 papers that have together received 541 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Virus-based gene therapy research (4 papers), Molecular Biology Techniques and Applications (3 papers), PARP inhibition in cancer therapy (3 papers), Lung Cancer Research Studies (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Oncology (211 citations), Cancer Research (79 citations), Cell Biology (67 citations), Immunology and Allergy (19 citations) and Molecular Biology (187 citations). Lisa Ley has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include J Koudstaal, G. Harms, Harry van Goor, Mj Hardonk, Lou A. Smets, Michael J. Pishvaian, John L. Marshall, J. L. V. Broers, G. Peter Vooijs and D. N. Carney. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, Histochemistry and Cell Biology, Proceedings of the National Academy of Sciences and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.